Skip to main content
logo
Initiator Pharma A/S (STO:INIT)
Sweden flag Sweden · Delayed Price · Currency is SEK
2.290
-0.140 (-5.76%)
Jul 24, 2026, 5:24 PM CET

Initiator Pharma Financials Overview

Millions DKK. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Profit
-23.91-14.83-11.07-23.41-38.43-21.63
Operating Income
-26.56-17.78-14.5-27.03-41.74-23.07
Net Income
-22.59-13.69-12.93-22.87-38.46-21.06
Earnings Per Share
-0.34-0.20-0.23-0.44-0.80-0.60
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
19.826.2513.3724.3439.1134.35
Total Debt
7.522.15015.4412.5813.29
Net Cash (Debt)
12.2824.113.378.926.5421.06
Net Cash Growth
13.91%80.21%50.25%-66.46%26.02%55.92%
Net Cash Per Share
0.190.350.240.160.500.53

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-26.95-17.73-12.08-17.65-32.7-34.1
Free Cash Flow
-26.95-17.73-12.08-17.65-32.7-34.1
Free Cash Flow Growth
------

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
-13.0811.2516.597.36-